Abstract:Previously, we and others have demonstrated that activation of peroxisome proliferator-activated receptor γ (PPARγ) by specific pharmacological agonists inhibits the pathogenesis of chronic hypoxia-induced pulmonary hypertension (CHPH) by suppressing the proliferation and migration in distal pulmonary arterial smooth muscle cells (PASMCs). Moreover, these beneficial effects of PPARγ are mediated by targeting the intracellular calcium homeostasis and store-operated calcium channel (SOCC) proteins, including the main caveolae component caveolin-1. However, other than the caveolin-1 targeted mechanism, in this study, we further uncovered a caveolin-1 dependent mechanism within the activation of PPARγ by the specific agonist GW1929. First, effective knockdown of caveolin-1 by small-interfering RNA (siRNA) markedly abolished the upregulation of GW1929 on PPARγ expression at both mRNA and protein levels; Then, in HEK293T, which has previously been reported with low endogenous caveolin-1 expression, exogenous expression of caveolin-1 significantly enhanced the upregulation of GW1929 on PPARγ expression compared with nontransfection control. In addition, inhibition of PPARγ by either siRNA or pharmacological inhibitor T0070907 led to increased phosphorylation of cellular mitogen-activated protein kinases ERK1/2 and p38. In parallel, GW1929 dramatically decreased the expression of the proliferative regulators (cyclin D1 and PCNA), whereas it increased the apoptotic factors (p21, p53, and mdm2) in hypoxic PASMCs. Furthermore, these effects of GW1929 could be partially reversed by recovery of the drug treatment. In combination, PPARγ activation by GW1929 reversibly drove the cell toward an antiproliferative and proapoptotic phenotype in a caveolin-1-dependent and -targeted mechanism.

Activation of PPARγ Inhibits HDAC1-mediated Pulmonary Arterial Smooth Muscle Cell Proliferation and Its Potential Mechanisms.

Involvement of CapG in Proliferation and Apoptosis of Pulmonary Arterial Smooth Muscle Cells and in Hypoxia-Induced Pulmonary Hypertension Rat Model

Activation of peroxisome proliferation–activated receptor‐γ inhibits transforming growth factor‐β1‐induced airway smooth muscle cell proliferation by suppressing Smad–miR‐21 signaling

Activation of AMPK Inhibits PDGF-induced Pulmonary Arterial Smooth Muscle Cells Proliferation and Its Potential Mechanisms.

PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway

SphK1/S1P Mediates PDGF-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation Via Mir-21/Bmprii/id1 Signaling Pathway

PPARγ activation inhibits PDGF-induced pulmonary artery smooth muscle cell proliferation and migration by modulating TERT

5-HT Induces PPAR Γ Reduction and Proliferation of Pulmonary Artery Smooth Muscle Cells Via Modulating GSK-3β/β-catenin Pathway

PPARγ Agonist Pioglitazone Inhibits PDGF-induced Pulmonary Artery Smooth Muscle Cells Proliferation and Migration via Modulating TERT

PPARδ Agonist GW501516 Inhibits PDGF-stimulated Pulmonary Arterial Smooth Muscle Cell Function Related to Pathological Vascular Remodeling.

Activation of PPAR-γ Inhibits PDGF-induced Proliferation of Mouse Renal Fibroblasts

Pharmacological Activation of PPARγ Inhibits Hypoxia-Induced Proliferation Through a Caveolin-1-targeted and -Dependent Mechanism in PASMCs

PDGF-induced airway smooth muscle proliferation is associated with Human antigen R activation and could be weakened by AMPK activation

Activation of AMPK Inhibits TGF-β1-induced Airway Smooth Muscle Cells Proliferation and Its Potential Mechanisms

Heme oxygenase-1/p21WAF1 mediates peroxisome proliferator-activated receptor-gamma signaling inhibition of proliferation of rat pulmonary artery smooth muscle cells.

Activation of PPAR-γ Ameliorates Pulmonary Arterial Hypertension Via Inducing Heme Oxygenase-1 and P21(waf1): an in Vivo Study in Rats.

Activation of AMPK inhibits pulmonary arterial smooth muscle cells proliferation.

INHIBITING EFFECTS OF DDPH ON PULMONARY ARTERIAL SMOOTH MUSCLE CELL PROLIFERATION AND ON THE DECREASED EXPRESSION OF α-SM-ACTIN INDUCED BY HYPOXIA ENDOTHELIA CELL CONDITIONED MEDIUM

MicroRNA-27a/b Mediates Endothelin-1-induced PPARγ Reduction and Proliferation of Pulmonary Artery Smooth Muscle Cells

Inhibition of YTHDF1 prevents hypoxia-induced pulmonary artery smooth muscle cell proliferation by regulating Foxm1 translation in an m6A-dependent manner

PARM1 Drives Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension via AKT/FOXO3A Axis